Communiqués Devyser Diagnostics AB

Actions

DVYSR

SE0016588867

Recherche biotechnologique et médicale

Temps Différé Nasdaq Stockholm 13:18:14 17/09/2026			Varia. 5j.	Varia. 1 janv.
54,90 ^SEK	-0,18%		-3,35%	-51,93%

16/09	Le PDG de Devyser achète des actions pour 54 000 couronnes	FW
04/09	L'actionnaire principal Arnhult renforce sa participation dans Devyser	FW

Communiqués

14/07	Invitation to audiocast for Devyser’s Q2 report 2026	AQ
06/05	Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 6 May 2026	AQ
27/04	Devyser Diagnostics AB publishes quarterly report for the period January to March 2026	AQ
22/04	Invitation to audiocast for Devyser’s Q1 report 2026	AQ
07/04	Devyser announces that Chief Commercial Officer will leave the company	AQ
01/04	Devyser completes acquisition of CyberGene AB and carries out issue of compensation shares	AQ
13/02	Devyser Diagnostics (Q4 Review): Jaw-dropping EBIT margin	AQ
12/02	Devyser Diagnostics AB publishes year-end report for January to December 2025	AQ
11/02	Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market	AQ
03/02	Invitation to presentation of Devyser’s Q4 2025 Interim Report	AQ
28/11	Devyser strengthens U.S. market presence with CMS pricing for PrenatalDetect RHD test	AQ
07/11	Devyser Diagnostics (Q3 Review) - Exaggerated reaction, strong Q4 ahead	AQ
05/11	Devyser Diagnostics AB publishes quarterly report for the period July to September 2025	AQ
29/10/25	Invitation to presentation of Devyser’s Q3 2025 Interim Report	AQ
22/09/25	Bulletin from an Extraordinary General Meeting in Devyser Diagnostics AB (publ) held on 22 September 2025	AQ
22/07/25	Devyser Diagnostics AB publishes quarterly report for the period April to June 2025	AQ
14/07/25	Invitation to presentation of Devyser’s Q2 2025 Interim Report	AQ
14/05/25	Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 14 May 2025	AQ
29/04/25	Devyser Diagnostics AB publishes quarterly report for the period January to March 2025	AQ
23/04/25	Invitation to audiocast for Devyser’s Q1 report 2025	AQ
13/02/25	Correction: Too low direct sales reported in year-end report "Devyser Diagnostics AB publishes year-end report for January to December 2024"	AQ
13/02/25	Devyser Diagnostics AB publishes year-end report for January to December 2024	AQ
07/02/25	Invitation to audiocast for Devyser’s Q4 report 2024	AQ
16/01/25	Devyser publishes preliminary result for Q4 2024	AQ
16/01/25	CEO Fredrik Alpsten leaves Devyser and Fredrik Dahl is appointed new acting CEO of Devyser	AQ